论文部分内容阅读
新药介绍──内皮素拮抗剂（Ｒｏ４７－０２０３ｂｏｓｅｎｔａｎ）瑞士Ｒｏｃｈｅ药厂最近开发一种新的内皮素拮抗剂（Ｒｏ４７－０２０３）．临床前实验证明该药是一种有效的慢性降压药物，并提示该药可能保护心血管靶器官免受损害，与ＡＣＥＩ合用可能有协同作用。近年...
Introduction of new drugs ─ ─ endothelin antagonist (Ro47-0203bosentan) Switzerland Roche Pharmaceuticals recently developed a new endothelin antagonist (Ro47-0203). Preclinical experiments show that the drug is an effective chronic antihypertensive drugs, and suggests that the drug may protect cardiovascular target organs from damage, and ACEI may have synergistic effect. in recent years...